A combination of the TLR4 agonist CIA05 and alum promotes the immune responses to Bacillus anthracis protective antigen in mice

International Immunopharmacology

Volumn 11, Issue 9, 2011, Pages 1195-1204

  Wui, Seo Ri ^a   Kim, Hye Kyeong ^a   Han, Ji Eun ^a   Kim, Jong Min ^a   Kim, Yeon Hee ^b   Chun, Jeong Hoon ^b   Cho, Yang Je ^c   Lee, Na Gyong ^a  

^a Sejong University   (South Korea)

^b Korea Centers for Disease Control and Prevention   (South Korea)

^c R and D Center EyeGene Inc   (South Korea)

Author keywords

Adjuvant; Alum; Anthrax vaccine; Bacillus anthracis protective antigen; Toll like receptor 4 agonist

Indexed keywords

ALUMINUM HYDROXIDE; ANTHRAX VACCINE; BACILLUS ANTHRACIS PROTECTIVE ANTIGEN; BACTERIAL ANTIGEN; CD24 ANTIGEN; CELL PROTEIN; CIA 05; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; PROTEIN GL7; RECOMBINANT ANTIGEN; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 4 AGONIST; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTHRAX; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG POTENTIATION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMALS; ANTHRAX; ANTHRAX VACCINES; ANTIBODIES, BACTERIAL; ANTIBODIES, NEUTRALIZING; ANTIGENS, BACTERIAL; ANTIGENS, DIFFERENTIATION; B-LYMPHOCYTES; BACILLUS ANTHRACIS; BACTERIAL TOXINS; IMMUNIZATION; IMMUNOGLOBULIN G; INTERLEUKINS; MALE; MICE; MICE, INBRED BALB C; PROTECTIVE AGENTS; RECOMBINANT PROTEINS; SPLEEN; TOLL-LIKE RECEPTOR 4;

EID: 80051906989     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.03.020     Document Type: Article

References (37)

1. M. Mock, and A. Fouet Anthrax Annu Rev Microbiol 55 2001 647 671 (Pubitemid 32978119)
2. G. Schmid, and A. Kaufmann Anthrax in Europe: its epidemiology, clinical characteristics, and role in bioterrorism Clin Microbiol Infect 8 2002 479 488 (Pubitemid 34993830)
3. R.J. Collier, and J.A. Young Anthrax toxin Annu Rev Cell Dev Biol 19 2003 45 70 (Pubitemid 37487342)
4. P.C. Turnbull Current status of immunization against anthrax: old vaccines may be here to stay for a while Curr Opin Infect Dis 13 2000 113 120 (Pubitemid 30223744)
5. A.M. Friedlander, and S.F. Little Advances in the development of next-generation anthrax vaccines Vaccine 5 Suppl 4 2009 D28 D32
6. A.M. Friedlander, P.R. Pittman, and G.W. Parker Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax JAMA 282 1999 2104 2106
7. J.L. Sever, A.I. Brenner, A.D. Gale, J.M. Lyle, L.H. Moulton, and B.J. Ward Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) Pharmacoepidemiol Drug Saf 13 2004 825 840 (Pubitemid 40003818)
8. P.R. Pittman, P.H. Gibbs, T.L. Cannon, and A.M. Friedlander Anthrax vaccine: short-term safety experience in humans Vaccine 20 2001 972 978 (Pubitemid 34015841)
9. P.R. Pittman, G. Kim-Ahn, D.Y. Pifat, K. Coonan, P. Gibbs, and S. Little Anthrax vaccine: immunogenicity and safety of a dose-reduction, route change comparison study in humans Vaccine 20 2002 1412 1420 (Pubitemid 34131683)
10. T. Ready US soldiers refuse to fall in line with anthrax vaccination scheme Nat Med 10 2004 112 (Pubitemid 38524869)
11. G.E. Rhie, M.H. Roehrl, M. Mourez, R.J. Collier, J.J. Mekalanos, and J.Y. Wang A dually active anthrax vaccine that confers protection against both bacilli and toxins Proc Natl Acad Sci USA 100 2003 10925 10930 (Pubitemid 37140129)
12. J.Y. Wang, and M.H. Roehrl Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin Med Immunol 4 2005 4 11
13. H. Xie, I. Gursel, B.E. Ivins, M. Singh, D.T. O'Hagan, and J.B. Ulmer CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine Infect Immun 73 2005 828 833 (Pubitemid 40165739)
14. M. Gu, P.M. Hine, W. James Jackson, L. Giri, and G.S. Nabors Increased potency of BioThrax anthrax vaccine with the addition of the C-class CpG oligonucleotide adjuvant CPG 10109 Vaccine 25 2007 526 534 (Pubitemid 44856098)
15. Y.S. Park, J.H. Lee, C.F. Hung, T.C. Wu, and T.W. Kim Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant Infect Immun 76 2008 1952 1959
16. Y.J. Cho, B.Y. Ahn, N.G. Lee, D.H. Lee, and D.S. Kim A combination of E. coli DNA fragments and modified lipopolysaccharides as a cancer immunotherapy Vaccine 24 2006 5862 5871 (Pubitemid 43947388)
17. E.S. Song, S.A. Park, S.H. Kim, Y.J. Cho, B.Y. Ahn, and B.C. Ahn Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen FEMS Immunol Med Microbiol 51 2007 496 504 (Pubitemid 350076159)
18. J.E. Han, H.K. Kim, S.A. Park, S.J. Lee, H.J. Kim, and G.H. Son A nontoxic derivative of lipopolysaccharide increases immune responses to Gardasil HPV vaccine in mice Int Immunopharmacol 10 2010 169 176
19. S.H. Kim, S.A. Park, H.K. Kim, Y.J. Cho, K.S. Kim, and Y.H. Kim Enhancement of the immune responses of mice to Bacillus anthracis protective antigen by CIA07 combined with alum Arch Pharm Res 31 2008 1385 1392
20. G. Rhie, Y. Park, J. Chun, C. Yoo, W. Seong, and H. Oh Expression and secretion of the protective antigen of Bacillus anthracis in Bacillus brevis FEMS Immunol Med Microbiol 45 2005 331 339 (Pubitemid 41040018)
21. C.H. Lee, and C.M. Tsai Quantification of bacterial lipopolysaccharides by the purpald assay: measuring formaldehyde generated from 2-keto-3- deoxyoctonate and heptose at the inner core by periodate oxidation Anal Biochem 267 1999 161 168
22. S.F. Little, B.E. Ivins, P.F. Fellows, M.L. Pitt, S.L. Norris, and G.P. Andrews Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine Vaccine 22 2004 422 430 (Pubitemid 37510273)
23. E.B. Lindblad Aluminium compounds for use in vaccines Immunol Cell Biol 82 2004 497 505 (Pubitemid 39421059)
24. D.M. Klinman, H. Xie, S.F. Little, D. Currie, and B.E. Ivins CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques Vaccine 22 2004 2881 2886 (Pubitemid 38900667)
25. D.M. Klinman, D. Currie, G. Lee, V. Grippe, and T. Merkel Systemic but not mucosal immunity induced by AVA prevents inhalational anthrax Microbes Infect 9 2007 1478 1483 (Pubitemid 350016979)
26. C.L. Cooper, H.L. Davis, M.L. Morris, S.M. Efler, M.A. Adhami, and A.M. Krieg CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study J Clin Immunol 24 2004 693 701 (Pubitemid 40933121)
27. S.L. Giannini, E. Hanon, P. Moris, M. Van Mechelen, S. Morel, and F. Dessy Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only Vaccine 24 2006 5937 5949 (Pubitemid 44080367)
28. N.C. Kong, J. Beran, S.A. Kee, J.L. Miguel, C. Sánchez, and J.M. Bayas A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients Kidney Int 73 2008 856 862 (Pubitemid 351398279)
29. S.A. Park, E.S. Song, Y.J. Cho, B.Y. Ahn, S.H. Ha, and B.L. Seong Immune responses of mice to influenza subunit vaccine in combination with CIA07 as an adjuvant Microbiol Immunol 51 2007 1099 1107
30. K.K. Peachman, M. Rao, C.R. Alving, R. Burge, S.H. Leppla, and V.B. Rao Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen Infect Immun 74 2006 794 797 (Pubitemid 43023142)
31. J.F. Hewetson, S.F. Little, B.E. Ivins, W.M. Johnson, P.R. Pittman, and J.E. Brown An in vivo passive protection assay for the evaluation of immunity in AVA-vaccinated individuals Vaccine 26 2008 4262 4266
32. I.C. MacLennan Germinal centers Annu Rev Immunol 12 1994 117 139 (Pubitemid 24140411)
33. C.L. Cozine, K.L. Wolniak, and T.J. Waldschmidt The primary germinal center response in mice Curr Opin Immunol 17 2005 298 302 (Pubitemid 40692665)
34. G. Laszlo, K.S. Hathcock, H.B. Dickler, and R.J. Hodes Characterization of a novel cell-surface molecule expressed on subpopulations of activated T and B cells J Immunol 150 1993 5252 5262 (Pubitemid 23180638)
35. L. Cervenak, A. Magyar, R. Boja, and G. László Differential expression of GL7 activation antigen on bone marrow B cell subpopulations and peripheral B cells Immunol Lett 78 2001 89 96 (Pubitemid 32728230)
36. M. Murasawa, S. Okada, S. Obata, M. Hatano, H. Moriya, and T. Tokuhisa GL7 defines the cycling stage of pre-B cells in murine bone marrow Eur J Immunol 32 2002 291 298 (Pubitemid 34092846)
37. P.J.L. Linton, D.J. Decker, and N.R. Klinman Primary antibody-forming cells and secondary B cells are generated from separate precursor cell subpopulations Cell 59 1989 1049 1059 (Pubitemid 20024616)